Delivery Order SPE2DB22D2206-SPE2DB26FDS21
- Not listed
- The Defense Logistics Agency awarded a $2,646.84 delivery order to AmerisourceBergen Drug Corp for 100 tablets of Methylphenidate ER 18 mg on August 11, 2025, with completion expected by August 12, 2025. This is a firm fixed-price, non-set-aside contract awarded competitively. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for federal medical procurement, particularly supporting military and veteran...
- The U.S. Defense Logistics Agency (DLA) awarded a $2,682.51 firm-fixed-price delivery order contract to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor, for the supply of 4,566,177,514 units of Methylphenidate ER 27 mg tablets. The contract has an ultimate completion date of October 23, 2024. AmerisourceBergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for providing a...
- The Defense Logistics Agency awarded a $1,863.10 firm fixed price delivery order to AmerisourceBergen Drug Corp for Methylphenidate ER 27 mg tablets (100 count) on September 17, 2025, with a completion date of September 18, 2025. This non-set-aside contract represents a pharmaceutical supply delivery to support federal medical needs. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical vendor for the federal government's...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,301.28 for Methylphenidate ER(LA) 10mg capsules (100-count) on September 23, 2025, with completion scheduled for September 24, 2025. This non-set-aside contract utilizes firm fixed pricing and represents a child order under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a comprehensive pharmaceutical supply vehicle valued at $999,999,999.00 and...
- The Defense Logistics Agency (DLA) awarded AmerisourceBergen Drug Corp a delivery order valued at $1,332.89 for Methylphenidate ER 54 mg tablets (100-count bottles) on September 23, 2025, with completion scheduled for September 24, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and represents a direct fulfillment of pharmaceutical supply needs for federal military and healthcare systems. The work will be performed at AmerisourceBergen's corporate office...
- The U.S. Defense Logistics Agency (DLA) has awarded a firm fixed price delivery order to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide 4,563,512,599 units of Methylphenidate ER 18 mg tablets in 100-count bottles. The $1,263.10 contract has a completion date of February 2, 2024. AmerisourceBergen Drug Corp is the prime contractor on this delivery order, which falls under a larger indefinite delivery contract (IDC) valued at up to $999,999,999.00 awarded by...
- The Defense Logistics Agency awarded a $1,471.36 delivery order to AmerisourceBergen Drug Corp for Methylphenidate ER 18 mg tablets (100-count) on August 1, 2025, with an ultimate completion date of August 4, 2025. This firm fixed-price contract represents a non-set-aside, competitively awarded delivery order under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical. The pharmaceutical product will be delivered to the vendor's corporate office location in...
- The Defense Logistics Agency awarded a $1,216.65 delivery order to AmerisourceBergen Drug Corp on October 17, 2025, for the supply of Methylphenidate ER 27 mg tablets (100-count bottles). This is a firm fixed price, competitively awarded delivery order with no set-aside designation and an ultimate completion date of October 20, 2025. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. As a major pharmaceutical distributor serving...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 22, 2025, for the supply of Methylphenidate ER 18 mg tablets (100-count bottles) with a firm fixed price ceiling value of $1,810.72. This non-set-aside, competitively awarded contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The product will be...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,438.08 for methylphenidate ER 36 mg tablets (100-count supply) on July 22, 2025, with ultimate completion by July 23, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and is being performed at the company's corporate office location in Conshohocken, Pennsylvania. The delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA...
- SPE2DB22D2206Indefinite Delivery Contract
- SPE2DB22D2206-SPE2DB26FDS21Delivery Order
The Defense Logistics Agency awarded a $2,928.65 delivery order to AmerisourceBergen Drug Corp for Methylphenidate ER(LA) 10mg tablets (100-count package) on October 20, 2025, with completion targeted for October 21, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and supports pharmaceutical supply to federal medical procurement needs. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a major pharmaceutical distributor for military and veteran healthcare systems through the Defense Logistics Agency's Medical Supply Chain. This delivery order represents a child contract issued under AmerisourceBergen's substantial Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. This prime IDC vehicle enables the company to supply a comprehensive range of pharmaceutical products, including specialty medications, brand-name and generic drugs, and medical supplies to support military healthcare programs globally. The contract supports customers including the Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems through flexible ordering mechanisms aligned with DLA's pharmaceutical procurement strategy.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.9k | 10/20/25 |